Molecular genetics of acute leukaemia Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Drug Resistance, Neoplasm
  • Models, Theoretical
  • Neoplasms

abstract

  • The outlook for patients with acute promyelocytic leukaemia has improved vastly with the use of all-trans retinoic acid. The development of this therapeutic agent stemmed from the finding that an abnormality of the retinoic acid receptor is involved in this disease. In the search for other molecular abnormalities in the acute leukaemias that might serve as therapeutic targets, the chromosomal translocations associated with this group of disorders have been helpful in indicating where to look for potential cancer genes. Some common signal-transduction pathways through which different such genes act have been identified, and compounds that interfere with these pathways are already being screened for.

publication date

  • January 18, 1997

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(96)07535-6

PubMed ID

  • 9111557

Additional Document Info

start page

  • 196

end page

  • 200

volume

  • 349

number

  • 9046